Protection From Cisplatin Ototoxicity by Lactated Ringers
NCT00584155
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
PI left the university.
Conditions
Hearing Loss
Interventions
DRUG:
Normal Saline and 0.3% ofloxacin
DRUG:
Lactated Ringer's with 0.03% Ofloxacin
Sponsor
University of Oklahoma